{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-11504376","patent":{"patent_number":"US-11504376","title":"Targeting DNA-PKCS and B7-H1 to treat cancer","assignee":null,"inventors":[],"filing_date":"2019-11-12T00:00:00.000Z","publication_date":"2022-11-22T00:00:00.000Z","cpc_codes":["C12Q","G01N","G01N","G01N","C12Q","G01N","G01N","G01N"],"num_claims":7,"abstract":"Materials and methods for treating potentially chemoresistant tumors (e.g., using DNA-PKcs inhibitors and anti-B7-H1 antibodies) are provided herein."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"Targeting DNA-PKCS and B7-H1 to treat cancer","description":"Materials and methods for treating potentially chemoresistant tumors (e.g., using DNA-PKcs inhibitors and anti-B7-H1 antibodies) are provided herein.","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-11504376","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-11504376","citation_suggestion":"Patentable. \"Targeting DNA-PKCS and B7-H1 to treat cancer\" (US-11504376). https://patentable.app/patents/US-11504376","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-11504376","json":"https://patentable.app/api/llm-context/US-11504376","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-05-31T01:54:56.457Z"}